Nanotechnology Now |
Our NanoNews Digest Sponsors
Alnylam Pharmaceuticals, Inc.
Alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as RNA interference, or RNAi. With RNAi technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.
300 Third Street, 3rd Floor
Cambridge, MA 02142 USA
617-551-8200
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
Subscribe to the Forbes/Wolfe Nanotech Report & Get 2 Free Reports
Nanotechnology Now Featured Books
| © Copyright 1999-2012 7thWave, Inc. All Rights Reserved | PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE |